Literature DB >> 18689544

Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.

Joshua Arnold1, Bevin Zimmerman, Min Li, Michael D Lairmore, Patrick L Green.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ) is dispensable for HTLV-1-mediated cellular transformation in cell culture, but is required for efficient viral infectivity and persistence in rabbits. In most adult T-cell leukemia (ATL) cells, Tax oncoprotein expression is typically low or undetectable, whereas Hbz gene expression is maintained, suggesting that Hbz expression may support infected cell survival and, ultimately, leukemogenesis. Emerging data indicate that HBZ protein can interact with cAMP response element binding protein (CREB) and Jun family members, altering transcription factor binding and transactivation of both viral and cellular promoters. Herein, lentiviral vectors that express Hbz-specific short hairpin (sh)-RNA effectively decreased both Hbz mRNA and HBZ protein expression in transduced HTLV-1-transformed SLB-1 T cells. Hbz knockdown correlated with a significant decrease in T-cell proliferation in culture. Both SLB-1 and SLB-1-Hbz knockdown cells engrafted into inoculated NOD/SCID(gammachain-/-) mice to form solid tumors that also infiltrated multiple tissues. However, tumor formation and organ infiltration were significantly decreased in animals challenged with SLB-1-Hbz knockdown cells. Our data indicate that Hbz expression enhances the proliferative capacity of HTLV-1-infected T cells, playing a critical role in cell survival and ultimately HTLV-1 tumorigenesis in the infected host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689544      PMCID: PMC2572803          DOI: 10.1182/blood-2008-04-154286

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  41 in total

1.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

2.  Human T-cell leukemia virus minus strand transcription in infected T-cells.

Authors:  D Larocca; L A Chao; M H Seto; T K Brunck
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

3.  The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Authors:  Jihane Basbous; Charlotte Arpin; Gilles Gaudray; Marc Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2003-08-22       Impact factor: 5.157

4.  Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator.

Authors:  Ihab Younis; Lyne Khair; Miroslav Dundr; Michael D Lairmore; Genoveffa Franchini; Patrick L Green
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

Authors:  M Zahidunnabi Dewan; Kazuo Terashima; Midori Taruishi; Hideki Hasegawa; Mamoru Ito; Yuetsu Tanaka; Naoki Mori; Tetsutaro Sata; Yoshio Koyanagi; Michiyuki Maeda; Yoko Kubuki; Akihiko Okayama; Masahiro Fujii; Naoki Yamamoto
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

6.  Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.

Authors:  J T Kimata; F H Wong; J J Wang; L Ratner
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

7.  Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells.

Authors:  Satoshi Takeda; Michiyuki Maeda; Shigeru Morikawa; Yuko Taniguchi; Jun-Ichirou Yasunaga; Kisato Nosaka; Yuetsu Tanaka; Masao Matsuoka
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

8.  HBZ interacts with JunD and stimulates its transcriptional activity.

Authors:  Sabine Thébault; Jihane Basbous; Patrick Hivin; Christian Devaux; Jean-Michel Mesnard
Journal:  FEBS Lett       Date:  2004-03-26       Impact factor: 4.124

Review 9.  The immune control and cell-to-cell spread of human T-lymphotropic virus type 1.

Authors:  Charles R M Bangham
Journal:  J Gen Virol       Date:  2003-12       Impact factor: 3.891

10.  HTLV-1 HBZ cooperates with JunD to enhance transcription of the human telomerase reverse transcriptase gene (hTERT).

Authors:  Anne-Sophie Kuhlmann; Julien Villaudy; Louis Gazzolo; Marc Castellazzi; Jean-Michel Mesnard; Madeleine Duc Dodon
Journal:  Retrovirology       Date:  2007-12-13       Impact factor: 4.602

View more
  108 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

3.  The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.

Authors:  Gunjan Choudhary; Lee Ratner
Journal:  Virology       Date:  2010-12-21       Impact factor: 3.616

Review 4.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

5.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Authors:  Valerio W Valeri; Anna Hryniewicz; Vibeke Andresen; Kathy Jones; Claudio Fenizia; Izabela Bialuk; Hye Kyung Chung; Risaku Fukumoto; Robyn Washington Parks; Maria Grazia Ferrari; Christophe Nicot; Valentina Cecchinato; Frank Ruscetti; Genoveffa Franchini
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

6.  Human T cell leukemia virus type 1 infection drives spontaneous proliferation of natural killer cells.

Authors:  Philip J Norris; Dale F Hirschkorn; Deborah A DeVita; Tzong-Hae Lee; Edward L Murphy
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

7.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

8.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

9.  Foxp3-dependent transformation of human primary CD4+ T lymphocytes by the retroviral protein tax.

Authors:  Li Chen; Dan Liu; Yang Zhang; Huan Zhang; Hua Cheng
Journal:  Biochem Biophys Res Commun       Date:  2015-09-14       Impact factor: 3.575

10.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.